华龙证券华龙内参2024年第48期，总第1607期（电子版）

Market Analysis - The overall market experienced a decline with over 3,500 stocks falling, indicating a decrease in risk appetite among investors. The trading volume in the Shanghai and Shenzhen markets was 1,007.2 billion, down by 47.6 billion from the previous trading day [6][19]. Northbound Capital - Northbound capital recorded a net purchase of 6.422 billion, with the Shanghai Stock Connect net buying 4.247 billion and the Shenzhen Stock Connect net buying 2.175 billion [8]. Key News - At the 2024 Xuan Tie RISC-V Ecosystem Conference, Damoyuan announced upgrades to several Xuan Tie processors, including the C907, which now supports matrix operations for AI acceleration. The next-generation flagship processor C930 is expected to launch within the year [11]. - The RISC-V architecture is positioned to potentially replace ARM's market position in various sectors due to its modular design, allowing chip designers to customize instruction sets for specific applications. Major companies and academic institutions have joined the RISC-V Foundation, indicating strong industry support [11]. - The Chinese innovative drug market is projected to grow significantly, with estimates suggesting a market size of 1,530.8 billion RMB by 2026 and further growth to 2,058.4 billion RMB by 2030. This growth is supported by government policies and the recovery of in-hospital treatments [11]. Stock Performance - Notable stocks that reached their daily limit include: - Ai Ai Precision Engineering (603580) with an increase of 9.99% [12]. - Zhongdian Xingfa (002298) with a 10.06% rise, focusing on algorithms, robotics, and optical storage [12]. - Xingguang Co. (002076) also saw a 10.00% increase, driven by lithium battery equipment [12]. Future Events Reminder - The report highlights the importance of upcoming events and developments in the market, particularly in sectors like innovative drugs and RISC-V technology, which are expected to shape future investment opportunities [14].